Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1427.20
-11.55 (-0.80%)
< Home < Back

Cipla voluntarily liquidates wholly-owned step-down subsidiary

Date: 08-03-2021

Cipla has voluntarily liquidated wholly-owned step-down subsidiary, Cipla (UK), with effect from March 5, 2021. This liquidation was a part of internal reorganization and it will not affect the performance or revenue of the company.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.